These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population.
    Author: Nong LG, Luo B, Zhang L, Nong HB.
    Journal: DNA Cell Biol; 2009 Oct; 28(10):507-13. PubMed ID: 19622039.
    Abstract:
    Nasopharyngeal carcinoma (NPC) is one of the most common cancers in southern China. In addition to environmental factors such as Epstein-Barr virus infection and chemical carcinogen exposure, genetic susceptibility has been reported to play a key role in the development of this disease. Interleukin-18 (IL-18) is a multifunctional cytokine that induces interferon-gamma secretion and plays an important role in antitumor immunity. Variations in the DNA sequence of the IL-18 gene promoter may lead to altered IL-18 production and/or activity, so this can modulate an individual's susceptibility to NPC. To test this hypothesis, we analyzed two single-nucleotide polymorphisms of IL-18 gene promoter, -137 G/C and -607 C/A, in 250 patients with NPC and 270 age- and sex-matched controls, using polymerase chain reaction-restriction fragment length polymorphism. Two polymorphisms, -137 G/C and -607 C/A, were in strong linkage disequilibrium. There were significant differences in the genotype and allele distribution of -137 G/C polymorphism of the IL-18 gene among cases and controls. The -137 GC and CC genotypes were associated with a significantly increased risk of NPC as compared with the -137 GG genotypes (odds ratio [OR] = 1.697; 95% confidence interval [CI], 1.158-2.488; p = 0.007, and OR = 2.700; 95% CI, 1.268-5.751; p = 0.008, respectively). Consistent with the results of the genotyping analyses, the -137 C/-607 A haplotype was associated with a significantly increased risk of NPC as compared with the -137 G/-607 C haplotype (OR = 1.721; 95% CI, 1.262-2.349; p = 0.001).
    [Abstract] [Full Text] [Related] [New Search]